Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 50.50% vs 1.70% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 366.84% vs 5.80% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 22.45% vs 50.18% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -48.48% vs 35.32% in Mar 2024
Compare Balance Sheet Results of Jenburkt Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.41
3.02
1.39
46.03%
Share Warrants & Outstandings
Total Reserve
167.36
194.15
-26.79
-13.80%
Shareholder's Funds
171.78
197.18
-25.40
-12.88%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
17.31
-17.31
-100.00%
Secured Loans
0.00
17.31
-17.31
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.38
13.59
-13.97
-102.80%
Other Long Term Liabilities
4.50
1.74
2.76
158.62%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
4.20
-4.20
-100.00%
Total Non-Current Liabilities
4.12
36.84
-32.72
-88.82%
Current Liabilities
Trade Payables
8.16
45.98
-37.82
-82.25%
Other Current Liabilities
7.08
14.85
-7.77
-52.32%
Short Term Borrowings
1.98
61.86
-59.88
-96.80%
Short Term Provisions
1.60
1.59
0.01
0.63%
Total Current Liabilities
18.82
124.30
-105.48
-84.86%
Total Liabilities
194.72
358.31
-163.59
-45.66%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
37.67
210.61
-172.94
-82.11%
Less: Accumulated Depreciation
25.15
62.15
-37.00
-59.53%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
12.52
148.46
-135.94
-91.57%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
40.28
0.40
39.88
9,970.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
20.56
23.23
-2.67
-11.49%
Long Term Loans & Advances
5.80
6.66
-0.86
-12.91%
Other Non Current Assets
56.89
0.00
56.89
0.00%
Total Non-Current Assets
138.19
180.52
-42.33
-23.45%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.88
60.58
-51.70
-85.34%
Sundry Debtors
20.73
64.53
-43.80
-67.88%
Cash and Bank
24.65
1.41
23.24
1,648.23%
Other Current Assets
1.48
7.20
-5.72
-79.44%
Short Term Loans and Advances
0.79
44.07
-43.28
-98.21%
Total Current Assets
56.53
177.79
-121.26
-68.20%
Net Current Assets (Including Current Investments)
37.71
53.49
-15.78
-29.50%
Total Current Assets Excluding Current Investments
56.53
177.79
-121.26
-68.20%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
194.72
358.31
-163.59
-45.66%
Contingent Liabilities
16.50
23.58
-7.08
-30.03%
Total Debt
1.98
79.17
-77.19
-97.50%
Book Value per share (adjusted)
389.23
652.19
-262.96
-40.32%
Annual - Borrowings
Borrowings 1.98 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 4.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 50.50% vs 1.70% in Mar 2024
Annual - Fixed Assets
Fixed Assets 52.80 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 366.84% vs 5.80% in Mar 2024
Annual - Investments
Investments 20.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 22.45% vs 50.18% in Mar 2024
Annual - Current Assets
Current Assets 56.53 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -48.48% vs 35.32% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
